Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity

Creative Commons License

KARA Z., Akcin R., DEMİR A. N., DİNÇ H. Ö., Taskin H. E., KOCAZEYBEK B. S., ...More

OBESITY SURGERY, vol.32, no.9, pp.2987-2993, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 9
  • Publication Date: 2022
  • Doi Number: 10.1007/s11695-022-06181-y
  • Journal Name: OBESITY SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.2987-2993
  • Keywords: Severe obesity, Vaccines, Antibody response, INFLAMMATION, COVID-19
  • Istanbul University Affiliated: Yes

Abstract

Aim Obesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim is to investigate the spike-protein receptor-binding domain antibody titers against BNT162b2 mRNA and inactivated SARS-CoV-2 (CoronaVac) vaccines in people with severe obesity. It is anticipated that the results to be obtained may provide invaluable information about future SARS-CoV-2 vaccination strategies in this vulnerable population.